Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer
Authors:
- Shang-Mian YieSYShang-Mian Yie
- Hong YangHYHong Yang
- Shang-Rong YeSYShang-Rong Ye
- Ke LiKLKe Li
- Dan-Dan DongDDDan-Dan Dong
- Xin-Mei LinXLXin-Mei Lin
- 1 November 2007
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 58 (2) , 267-274
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Soluble HLA-G molecules are increased in lymphoproliferative disordersHuman Immunology, 2003
- Biology and functions of human leukocyte antigen‐G in health and sickness*Tissue Antigens, 2003
- HLA-G Molecules: from Maternal–Fetal Tolerance to Tissue Acceptance2003
- Lung Cancer — Time to Move on from ChemotherapyNew England Journal of Medicine, 2002
- Human Leukocyte Antigen G Up-Regulation in Lung Cancer Associates with High-Grade Histology, Human Leukocyte Antigen Class I Loss and Interleukin-10 ProductionThe American Journal of Pathology, 2001
- KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factorCancer, 1998
- Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.Journal of Clinical Oncology, 1998
- In vivo influence of p53 status on proliferation and chemoradiosensitivity in non-small-cell lung cancerJournal of Cancer Research and Clinical Oncology, 1998
- Non-small cell lung cancer: clinical value of new biological predictorsLung Cancer, 1997
- Prognostic Significance of the Proliferation Index in Surgically Resected Non—Small-Cell Lung CancerArchives of Surgery, 1993